Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma in Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchWithdrawnNCT02610920
What this trial is testing

Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection

Who this might be right for
Breast NeoplasmCarcinoma, Ductal, BreastCarcinoma, Intraductal, Noninfiltrating
Columbia University
Not applicableStudy completedNCT00321048
What this trial is testing

Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC

Who this might be right for
Breast NeoplasmsCarcinoma, DuctalAdenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 57
Large-scale testing (Phase 3)Active Not RecruitingNCT02954874
What this trial is testing

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Breast Carcinoma In SituInvasive Breast CarcinomaStage I Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 1,195
Large-scale testing (Phase 3)Study completedNCT00402779
What this trial is testing

Erlotinib Prevention of Oral Cancer (EPOC)

Who this might be right for
Oral Cancer
M.D. Anderson Cancer Center 303
Not applicableStudy completedNCT00605982
What this trial is testing

Breast MRI as a Preoperative Tool for DCIS

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Memorial Sloan Kettering Cancer Center 115
Early research (Phase 1)Not Yet RecruitingNCT07725796
What this trial is testing

Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNMIBCUrothelial Carcinoma Bladder+5 more
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. 30
Not applicableStudy completedNCT00665782
What this trial is testing

Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast

Who this might be right for
Anxiety DisorderBreast CancerDepression+1 more
Wake Forest University Health Sciences 24
Testing effectiveness (Phase 2)Looking for participantsNCT05951179
What this trial is testing

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 131
Early research (Phase 1)Ended earlyNCT03735290
What this trial is testing

Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+1 more
Mendus 21
Very early researchActive Not RecruitingNCT02872025
What this trial is testing

Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)

Who this might be right for
Carcinoma, Intraductal, Noninfiltrating
Laura Esserman 42
Not applicableStudy completedNCT00148655
What this trial is testing

Educational Interventions for Patients With DCIS

Who this might be right for
DCIS
Dana-Farber Cancer Institute 120
Large-scale testing (Phase 3)Looking for participantsNCT07762885
What this trial is testing

Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery

Who this might be right for
Ductal Carcinoma In Situ, DCIS
Fudan University 636
Large-scale testing (Phase 3)Study completedNCT02311959
What this trial is testing

Therapeutic Nipple Sparing Mastectomy.

Who this might be right for
Breast Cancer
Institut Claudius Regaud 450
Testing effectiveness (Phase 2)Study completedNCT04293679
What this trial is testing

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC

Who this might be right for
Bowen's DiseaseCutaneous Squamous Cell Carcinoma in Situ
Sirnaomics 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT00909909
What this trial is testing

Radiation Therapy in Treating Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 200
Not applicableLooking for participantsNCT02402244
What this trial is testing

Project: Every Child for Younger Patients With Cancer

Who this might be right for
Adrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System Neoplasm+15 more
Children's Oncology Group 75,000
Early research (Phase 1)Active Not RecruitingNCT05340673
What this trial is testing

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast Carcinoma
City of Hope Medical Center 208
Not applicableStudy completedNCT01620853
What this trial is testing

Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Applied Spectral Imaging Ltd. 1
Large-scale testing (Phase 3)Looking for participantsNCT07480356
What this trial is testing

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNon-Muscle Invasive Bladder CarcinomaNon-muscle Invasive Bladder Cancer With Carcinoma in Situ
Protara Therapeutics 284
Testing effectiveness (Phase 2)Study completedNCT00952731
What this trial is testing

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Who this might be right for
Ductal Breast Carcinoma in SituEstrogen Receptor-positive Breast Cancer
Northwestern University 27
Next Page